Category: Pharma Industry

J&J Lawsuit to Test Trump Administration’s Stance on 340B Rebates

November 15, 2024 William Newton, Associate Editor/Senior Writer Views

J&J sued HRSA on Nov. 12 for threatening enforcement action that led the drugmaker to withdraw its 340B rebate proposal.

Johnson & Johnson’s (J&J’s) lawsuit challenging the federal government’s opposition to 340B rebates will test whether the Trump administration is [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

AbbVie, GSK Announce Refunds for 340B Overcharges

November 13, 2024 Bella Czajkowski, National Correspondent Views

AbbVie and GSK announced they will refund 340B providers for certain medications following ceiling price recalculations.

Drugmakers AbbVie and GlaxoSmithKline (GSK) will refund 340B providers for some products following ceiling price recalculations, according to notices posted [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

J&J Sues HRSA for Blocking Controversial 340B Rebate Model

November 12, 2024 William Newton, Associate Editor/Senior Writer Views

J&J is suing the federal government to implement the drugmaker's controversial 340B rebate proposal.

Johnson & Johnson (J&J) earlier today sued the federal government to establish a 340B rebate model, marking the latest escalation [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Arkansas Officials, Providers Urge Supreme Court to Deny PhRMA’s Appeal to Overturn 340B Contract Pharmacy Access Law

November 7, 2024 William Newton, Associate Editor/Senior Writer Views

Attorneys for the state of Arkansas and local providers argued the Supreme Court should not take up PhRMA's appeal to overturn a state 340B law.

Arkansas state officials and providers are urging the U.S. Supreme Court not to take up a drug industry trade group’s [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

State Contract Pharmacy Lawsuit Weekly Roundup: Updates in West Virginia, Missouri, Kansas

November 7, 2024 Shannon Young, William Newton and Bella Czajkowski, Associate Editor/Senior Writer Views

Key briefs were filed this week in state contract pharmacy litigation in West Virginia, Missouri and Kansas.

Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Lilly Backs Sanofi Lawsuit Seeking HRSA 340B Records, Argues Contract Pharmacy Agreements Violate 340B Statute

November 5, 2024 William Newton, Associate Editor/Senior Writer Views

Eli Lilly has filed an amicus brief in support of Sanofi's lawsuit seeking 340B contract pharmacy agreements from HRSA.

Eli Lilly is backing Sanofi’s lawsuit to compel the federal government to release all 340B contract pharmacy agreements, arguing that [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

BI Tightens Contract Pharmacy Restrictions for All Covered Entities

November 5, 2024 William Newton, Associate Editor/Senior Writer Views

Boehringer Ingelheim recently announced it will tighten its 340B contract pharmacy restrictions by requiring claims data submission.

Drugmaker Boehringer Ingelheim (BI) will begin requiring all 340B covered entities to submit claims data to continue accessing 340B drugs [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Eli Lilly Announces Refunds for 340B Overcharges

November 5, 2024 Bella Czajkowski, National Correspondent Views

Eli Lilly announced that it will refund 340B covered entities that purchased certain medications following adjustments to their ceiling prices.

Eli Lilly announced that it will refund 340B covered entities that purchased certain medications following adjustments to their ceiling prices. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Pfizer CEO Calls 340B ‘One of the Biggest Issues’ During Earnings Call Touting $17.1B in Quarterly Revenue

October 31, 2024 William Newton, Associate Editor/Senior Writer Views

Pfizer CEO Albert Bourla told investors that "340B reform is something that myself and the entire pharma [industry] is setting as a priority."

Pfizer’s top executive told investors this week that the 340B program “is one of the biggest issues,” during an earnings [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

State Contract Pharmacy Lawsuit Weekly Roundup: Updates in Arkansas, Missouri – Oct 24

October 31, 2024 William Newton, Associate Editor/Senior Writer Views

Key briefs were filed this week in state contract pharmacy litigation in Arkansas and Missouri.

Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Breaking News

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Staff Email

Site Footer Live